Sep 13, 2022 / 05:30PM GMT
Valerie Dixon - Morgan Stanley - MD
Hi everybody. We'll get started. Good afternoon. My name is Valerie Dixon. I'm a Managing Director that covers the life sciences tools and diagnostics space in Morgan Stanley's investment banking team. Very excited to host Bio-Techne in our fireside chat this afternoon. We have Jim Hippel, the CFO; and David Clair, the Head of Investor Relations.
But first for important disclosures, please see the Morgan Stanley research disclosure website at morganstanley.com/researchdisclosures. If you have any questions, please reach out to your sales rep.
With that out of the way, we can get started. So Jim, thanks for being here.
James T. Hippel - Bio-Techne Corporation - Executive VP of Finance & CFO
Thanks for having us.
Valerie Dixon - Morgan Stanley - MD
We'd love to give you an opportunity to, if you don't mind, just spend a few minutes to tell folks who aren't familiar with the story. We should be by now, a little bit introduction and your latest thoughts on Bio
Bio-Techne Corp at Morgan Stanley Global Healthcare Conference Transcript
Sep 13, 2022
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers